Development of a latency model for HIV-1 subtype C and the impact of long terminal repeat element genetic variation on latency reversal.

IF 3.5 4区 医学 Q2 IMMUNOLOGY Journal of Virus Eradication Pub Date : 2024-12-13 eCollection Date: 2024-12-01 DOI:10.1016/j.jve.2024.100575
Shreyal Maikoo, Robert-Jan Palstra, Krista L Dong, Tokameh Mahmoudi, Thumbi Ndung'u, Paradise Madlala
{"title":"Development of a latency model for HIV-1 subtype C and the impact of long terminal repeat element genetic variation on latency reversal.","authors":"Shreyal Maikoo, Robert-Jan Palstra, Krista L Dong, Tokameh Mahmoudi, Thumbi Ndung'u, Paradise Madlala","doi":"10.1016/j.jve.2024.100575","DOIUrl":null,"url":null,"abstract":"<p><p>Sub-Saharan Africa accounts for almost 70 % of people living with HIV (PLWH) worldwide, with the greatest numbers centred in South Africa where 98 % of infections are caused by subtype C (HIV-1C). However, HIV-1 subtype B (HIV-1B), prevalent in Europe and North America, has been the focus of most cure research and testing despite making up only 12 % of HIV-1 infections globally. Development of latency models for non-subtype B viruses is a necessary step to address this disproportionate focus. Furthermore, the impact of genetic variation between viral subtypes, specifically within the long terminal repeat (LTR) element of the viral transcriptional promoter on latency reversal, remains unclear. To address this scientific gap, we constructed a minimal genome retroviral vector expressing HIV-1C consensus transactivator of transcription protein (Tat) and green fluorescent protein (GFP) under the control of either HIV-1C consensus LTR (C731CC) or the transmitted/founder (T/F) LTRs derived from PLWH (C<sub>T/F</sub>731CC), produced corresponding LTR pseudotyped viruses using a vesicular stomatitis virus (VSV-G) pseudotyped Envelope vector and the pCMVΔR8.91 packaging vector containing HIV-1 accessory and <i>rev</i> genes. Viruses produced in this way were used to infect Jurkat E6 and primary CD4<sup>+</sup> T cells <i>in vitro</i>. By enriching for latently infected cells, and treating them with different latency reversing agents, we developed an HIV-1C latency model that demonstrated that the HIV-1C consensus LTR has lower reactivation potential compared to its HIV-1B counterpart. Furthermore, HIV-1C T/F LTR pseudotyped proviral genetic variants exhibited a heterogenous reactivation response which was modulated by host cell (genetic) variation. Our data suggests that genetic variation both within and between HIV-1 subtypes influences latency reversal. Future studies should investigate the specific role of variation in host cellular environment on reactivation differences.</p>","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 4","pages":"100575"},"PeriodicalIF":3.5000,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11730875/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Virus Eradication","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jve.2024.100575","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Sub-Saharan Africa accounts for almost 70 % of people living with HIV (PLWH) worldwide, with the greatest numbers centred in South Africa where 98 % of infections are caused by subtype C (HIV-1C). However, HIV-1 subtype B (HIV-1B), prevalent in Europe and North America, has been the focus of most cure research and testing despite making up only 12 % of HIV-1 infections globally. Development of latency models for non-subtype B viruses is a necessary step to address this disproportionate focus. Furthermore, the impact of genetic variation between viral subtypes, specifically within the long terminal repeat (LTR) element of the viral transcriptional promoter on latency reversal, remains unclear. To address this scientific gap, we constructed a minimal genome retroviral vector expressing HIV-1C consensus transactivator of transcription protein (Tat) and green fluorescent protein (GFP) under the control of either HIV-1C consensus LTR (C731CC) or the transmitted/founder (T/F) LTRs derived from PLWH (CT/F731CC), produced corresponding LTR pseudotyped viruses using a vesicular stomatitis virus (VSV-G) pseudotyped Envelope vector and the pCMVΔR8.91 packaging vector containing HIV-1 accessory and rev genes. Viruses produced in this way were used to infect Jurkat E6 and primary CD4+ T cells in vitro. By enriching for latently infected cells, and treating them with different latency reversing agents, we developed an HIV-1C latency model that demonstrated that the HIV-1C consensus LTR has lower reactivation potential compared to its HIV-1B counterpart. Furthermore, HIV-1C T/F LTR pseudotyped proviral genetic variants exhibited a heterogenous reactivation response which was modulated by host cell (genetic) variation. Our data suggests that genetic variation both within and between HIV-1 subtypes influences latency reversal. Future studies should investigate the specific role of variation in host cellular environment on reactivation differences.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
HIV-1亚型C潜伏期模型的建立及长末端重复元件遗传变异对潜伏期逆转的影响
撒哈拉以南非洲占全球艾滋病毒感染者(PLWH)的近 70%,其中南非的感染者人数最多,98%的感染是由 C 亚型(HIV-1C)引起的。然而,流行于欧洲和北美的 HIV-1 B 亚型(HIV-1B)尽管只占全球 HIV-1 感染者的 12%,却一直是大多数治愈研究和测试的重点。开发非 B 亚型病毒的潜伏模型是解决这一过度关注问题的必要步骤。此外,病毒亚型之间的基因变异,特别是病毒转录启动子长末端重复(LTR)元件内的基因变异对潜伏逆转的影响仍不清楚。为了弥补这一科学空白,我们构建了一种最小基因组逆转录病毒载体,在 HIV-1C 共识 LTR(C731CC)或来自 PLWH 的传输/创始(T/F)LTR(CT/F731CC)的控制下表达 HIV-1C 共识转录激活蛋白(Tat)和绿色荧光蛋白(GFP)、使用水泡性口炎病毒(VSV-G)伪型包膜载体和 pCMVΔR8.91 包装载体,其中含有 HIV-1 辅助基因和 rev 基因。用这种方法产生的病毒在体外感染 Jurkat E6 细胞和原代 CD4+ T 细胞。通过富集潜伏感染的细胞并用不同的潜伏逆转剂处理这些细胞,我们建立了一个 HIV-1C 潜伏模型,该模型证明 HIV-1C 共识 LTR 与 HIV-1B 对应基因相比具有更低的再激活潜能。此外,HIV-1C T/F LTR 伪型前病毒基因变体表现出异质性的再激活反应,这种反应受宿主细胞(基因)变异的调节。我们的数据表明,HIV-1 亚型内部和之间的基因变异都会影响潜伏期的逆转。未来的研究应探讨宿主细胞环境变异对再激活差异的具体作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Virus Eradication
Journal of Virus Eradication Medicine-Public Health, Environmental and Occupational Health
CiteScore
6.10
自引率
1.80%
发文量
28
审稿时长
39 weeks
期刊介绍: The Journal of Virus Eradication aims to provide a specialist, open-access forum to publish work in the rapidly developing field of virus eradication. The Journal covers all human viruses, in the context of new therapeutic strategies, as well as societal eradication of viral infections with preventive interventions. The Journal is aimed at the international community involved in the prevention and management of viral infections. It provides an academic forum for the publication of original research into viral reservoirs, viral persistence and virus eradication and ultimately development of cures. The Journal not only publishes original research, but provides an opportunity for opinions, reviews, case studies and comments on the published literature. It focusses on evidence-based medicine as the major thrust in the successful management of viral infections.The Journal encompasses virological, immunological, epidemiological, modelling, pharmacological, pre-clinical and in vitro, as well as clinical, data including but not limited to drugs, immunotherapy and gene therapy. It is an important source of information on the development of vaccine programs and preventative measures aimed at virus eradication.
期刊最新文献
Fixation and reversion of mutations in the receptor-binding domain of the SARS-CoV-2 spike protein: A 2020-2024 analysis. Bypassing primary antiretroviral therapy centres in Sub-Saharan Africa: An integrative review of the theoretical and empirical literature. Development of a latency model for HIV-1 subtype C and the impact of long terminal repeat element genetic variation on latency reversal. Assessing favipiravir impact on SARS-CoV-2 transmission within households: Insights from a multi-center study (FaviPrev). Hepatitis B prevalence in an endemic area of hepatitis C virus: A population-based study implicated in hepatitis elimination in Thailand.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1